The Scientist

» cancer

Most Recent

image: Cancer Research ROI

Cancer Research ROI

By | June 16, 2014

Report quantifies the returns from the U.K.’s investments in oncology.

2 Comments

image: Week in Review: June 9–13

Week in Review: June 9–13

By | June 13, 2014

Ancient apoptotic pathway connects humans to coral; lab-grown, light-sensing retinal tissue; tracking cancer with synthetic phospholipids; diving deep into the lung microbiome

0 Comments

Scientists generate tumor-targeting molecules that can be used for imaging and treatment.

0 Comments

image: Genome Digest

Genome Digest

By | June 11, 2014

What researchers are learning as they sequence, map, and decode species’ genomes

0 Comments

image: Contributors

Contributors

By | June 1, 2014

Meet some of the people featured in the June 2014 issue of The Scientist

0 Comments

image: Tactical Maneuvers

Tactical Maneuvers

By | June 1, 2014

Scientists are creating viruses that naturally home in on tumor cells while simultaneously boosting the body’s immune system to fight cancer.

2 Comments

image: Targeting Tumors with Viruses

Targeting Tumors with Viruses

By | June 1, 2014

Stephanie Swift discusses the strategy of fighting cancer with viruses.

0 Comments

image: Week in Review: May 19–23

Week in Review: May 19–23

By | May 23, 2014

Sperm-sex–sensing sows; blocking a pain receptor extends lifespan in mice; stop codons can code for amino acids; exploring the tumor exome

0 Comments

image: Making Sense of the Tumor Exome

Making Sense of the Tumor Exome

By | May 18, 2014

An algorithm can pick out biologically and clinically meaningful variants from whole-exome sequences of tumors.

0 Comments

image: IDing Cancer with 3-D Genomics

IDing Cancer with 3-D Genomics

By | May 7, 2014

In a proof-of-principle study, scientists show that the three-dimensional shape of a cancer cell genome can reliably classify subtypes of human leukemia.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech